tirzepatide vs semaglutide review and key differences, weight loss results (2026) Tirzepatide vs. Semaglutide for Weight

Doctors need to watch patients on GLP-1 for signs of gastroparesis

Only one TB-500 human study has reported mild side effects following 14 days of therapy in 10 subjects at singles doses of 42-1260mg

The findings demonstrate a significant mean HbA1c reduction of 1.2%, showing a meaningful effect on glycemic control

Tirzepatide is also used to help lose weight and keep the weight off in patients with obesity caused by certain conditions

Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Schnaidt S, Zeller C, Schnee JM, Anker SD

It is important to distinguish between correlation and causation when evaluating these concerns